|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.08 SEK | -1.94% |
|
-11.88% | -16.48% |
| Mar. 25 | Senzagen Receives Follow-Up Order Worth SEK 0.8 Million from the Global Chemicals Leader | CI |
| Mar. 22 | SenzaGen AB Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
SenzaGen AB reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was SEK 15.42 million compared to SEK 7.96 million a year ago. Net loss was SEK 31.35 million compared to SEK 27.17 million a year ago.
Basic loss per share from continuing operations was SEK 1.35 compared to SEK 1.27 a year ago. Diluted loss per share from continuing operations was SEK 1.35 compared to SEK 1.27 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -16.48% | 13.74M | |
| -15.64% | 11.33B | |
| +39.24% | 3.16B | |
| -18.79% | 2.04B | |
| -34.97% | 2.14B | |
| -27.84% | 1.49B | |
| +12.52% | 975M | |
| -4.37% | 731M | |
| -48.78% | 364M | |
| +26.64% | 371M |
SENZAGEN AB 
